SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

REGOLI, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.066
AS - Asia 5.440
EU - Europa 3.344
SA - Sud America 753
AF - Africa 112
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.728
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.870
SG - Singapore 2.111
CN - Cina 1.453
DE - Germania 859
VN - Vietnam 598
UA - Ucraina 577
BR - Brasile 576
IT - Italia 425
GB - Regno Unito 394
HK - Hong Kong 394
TR - Turchia 367
FI - Finlandia 346
FR - Francia 205
RU - Federazione Russa 145
SE - Svezia 134
IN - India 111
JP - Giappone 111
CA - Canada 107
MX - Messico 65
BD - Bangladesh 57
AR - Argentina 56
PL - Polonia 48
ZA - Sudafrica 47
IQ - Iraq 43
BE - Belgio 42
NL - Olanda 40
PK - Pakistan 36
ES - Italia 31
LT - Lituania 30
CO - Colombia 29
EC - Ecuador 28
ID - Indonesia 28
UZ - Uzbekistan 21
VE - Venezuela 17
MA - Marocco 16
AE - Emirati Arabi Uniti 14
CL - Cile 14
MY - Malesia 13
PH - Filippine 13
SA - Arabia Saudita 13
EG - Egitto 11
PE - Perù 10
PY - Paraguay 10
TN - Tunisia 10
AU - Australia 9
UY - Uruguay 9
AL - Albania 8
AT - Austria 8
CZ - Repubblica Ceca 8
BG - Bulgaria 7
IR - Iran 7
JO - Giordania 7
IL - Israele 6
KE - Kenya 6
LB - Libano 6
SN - Senegal 6
DO - Repubblica Dominicana 5
NP - Nepal 5
CH - Svizzera 4
ET - Etiopia 4
HR - Croazia 4
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
HN - Honduras 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
PA - Panama 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SV - El Salvador 3
AZ - Azerbaigian 2
BJ - Benin 2
CY - Cipro 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
IE - Irlanda 2
KH - Cambogia 2
KR - Corea 2
MN - Mongolia 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 20.714
Salva come PNG Salva come JPEG
Città #
Singapore 1.411
Ashburn 1.176
Fairfield 1.109
Woodbridge 1.076
Houston 665
Jacksonville 615
San Jose 595
Ann Arbor 559
Chandler 519
Beijing 474
Santa Clara 442
Seattle 410
Wilmington 392
Hong Kong 390
Cambridge 352
Munich 342
Ho Chi Minh City 199
Izmir 193
Nanjing 178
Los Angeles 171
New York 159
Helsinki 152
Milan 135
Hanoi 132
Dallas 124
Princeton 118
San Diego 111
Tokyo 109
Boardman 100
Lauterbourg 97
Shanghai 77
Turku 71
Orem 65
São Paulo 62
Nanchang 58
Dearborn 56
Shenyang 51
London 48
Frankfurt am Main 46
Falls Church 44
Brussels 40
Denver 36
Warsaw 36
Brooklyn 35
Mexico City 35
Buffalo 34
Bremen 33
Falkenstein 33
Hefei 33
Hebei 32
Tianjin 32
Ferrara 31
Johannesburg 30
Auburn Hills 29
Jiaxing 29
Montreal 29
Changsha 28
Toronto 28
Da Nang 27
Jinan 27
Mountain View 27
San Mateo 27
Phoenix 26
Atlanta 25
Manchester 23
Mcallen 22
Norwalk 22
Philadelphia 22
Chennai 21
Moscow 21
Haiphong 20
Redwood City 20
Rio de Janeiro 20
Addison 19
Boston 19
Chicago 19
Poplar 19
Tashkent 19
The Dalles 19
Kunming 18
San Francisco 18
Stockholm 18
Zhengzhou 18
Baghdad 17
Montréal 17
Amsterdam 16
Mumbai 16
Bexley 15
Curitiba 14
Dhaka 13
Hải Dương 13
Lahore 13
Guangzhou 12
Indiana 12
Ningbo 12
Tappahannock 12
Ankara 11
Belo Horizonte 11
Biên Hòa 10
Des Moines 10
Totale 14.426
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 391
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 335
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 307
A new selective antagonist of the nociceptin receptor 269
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 268
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 265
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 259
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 257
A new ligand for the urotensin II receptor 252
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 244
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 235
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 234
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 232
Ala scan analogues of HOE 140. Synthesis and biological activities 228
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 227
Effects of vasoactive agents in healthy and diseased human saphenous veins 226
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 224
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 219
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 218
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 217
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 216
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 213
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 212
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 211
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 210
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 209
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 209
B1 and B2 kinin receptors in various species 208
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 207
Pharmacological characterisation of novel kinin B2 receptor ligands 206
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 206
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 205
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 204
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 204
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 201
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 200
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 198
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 198
Pharmacological characterization of nociceptin receptor: an in vitro study 197
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 196
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 195
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 193
Structure-activity study at positions 3 and 4 of human neuropeptide S. 192
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 192
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 192
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 192
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 192
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 184
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 182
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 182
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 182
Characterization of the human vascular kinin B2 receptor by binding assays. 180
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 180
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 179
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 178
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 174
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 173
Structure-activity relationship study on human urotensin II 172
Nociceptin/orphanin FQ receptor ligands 171
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 169
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 169
Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells 169
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 169
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 168
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 167
ANTAGONISTI DEL RECETTORE UT E LORO USI TERAPEUTICI 166
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 165
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 164
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 163
Pharmacology of nociceptin and its receptor: a novel therapeutic target 160
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 159
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 159
Characterization of endothelin receptors in the human umbilical artery and vein 159
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 157
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 156
Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin 156
Pharmacology of the Kallikrein-Kinin system 156
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 155
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 154
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats 153
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 152
Receptors for kinins in the human isolated umbilical vein 151
Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT(1) and AT(2) receptors 151
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 150
Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation 144
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 143
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 139
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 139
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 137
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 136
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 131
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 131
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test 131
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 128
Characterization of the human vascular kinin B2 receptor by binding assays 126
Pharmacological characterisation of [(pX)Phe(4)]nociceptin(1-13)amide analogues - 1. In vitro studies 124
Identificazione di un antagonista del recettore UT 123
Expression and biological activity of B1 bradykinin receptors in two experimental models of epilepsy 121
Identificazione di un agonista parziale del recettore per il neuropeptide S 119
Highly potent full and partial agonists and anatagonists of the nociceptin/orphanin FQ receptor 117
Totale 18.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021434 0 0 0 0 0 0 0 0 0 166 204 64
2021/20221.308 44 137 96 98 87 56 73 72 57 94 123 371
2022/20231.332 125 50 62 168 224 176 112 100 196 7 68 44
2023/2024631 76 78 37 16 39 133 21 42 13 12 14 150
2024/20252.785 54 51 206 106 337 315 133 177 397 244 405 360
2025/20267.011 827 316 632 996 1.142 479 896 341 703 679 0 0
Totale 20.833